Efficacy and safety outcomes of proposed randomized controlled trials investigating hydroxychloroquine and chloroquine during the early stages of the COVID19 pandemic, BJCP

Analysis found that the 51 registered RCTs investigating hydroxychloroquine or chloroquine during the early stages of the COVID ‐19 pandemic included heterogeneous and insufficient approaches to measure efficacy/effectiveness and safety relevant to patients and clinical practice.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news